Are biotechs underestimating regulatory groundwork
Bio matters
Related Posts
NICE recommends Sogroya for growth hormone deficiency in children
Treatment provides option for children with growth failure The National Institute for Health and Care Excellence (NICE) has recommended Sogroya (somapacitan injection) for children aged […]
Tris Pharma announces positive results from ALLEVIATE-1 trial of cebranopadol
Phase 3 trial shows promising pain relief for acute pain patients Tris Pharma, Inc. has announced positive results from its ALLEVIATE-1 phase 3 clinical trial […]
Nine UCL researchers secure £560m in research funding from ERC
Approximately 14% of the competition-submitted proposals were selected to receive funding Nine researchers from University College London (UCL) have secured nearly £560m in funding from […]